Browse studies, page 137
Page 137 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis Research Square, 2024
- Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox Pharmaceuticals, 2022
- Azole Antifungals and DMI Fungicides: History, Activity, Synthesis, Resistance, MoA , and SAR 2026
- Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir Medicinal Chemistry Research, 2021
- Progress and Prospects of Triazoles in Advanced Therapies for Parasitic Diseases Tropical Medicine and Infectious Disease, 2025
- Updated Perspectives on The Diagnosis, Management And Novel Drug Delivery Strategies For The Treatment Of Onychomycosis Journal of Pharmaceutical Negative Results, 2022
- Eumycetoma: pathogenesis, current treatments, and the search for new drugs Applied Microbiology and Biotechnology, 2025
- Molecular docking approaches in mycetoma: Toward improved patient management PLoS neglected tropical diseases, 2026
- Internet questionnaire of attitude survey for patients with onychomycosis on treatment continuation 日本臨床皮膚科医会雑誌, 2019
- Cutaneous Fungal Infections Caused by Dermatophytes and Non-Dermatophytes: An Updated Comprehensive Review of Epidemiology, Clinical Presentations, and Diagnostic Testing Journal of Fungi, 2023
- Antifungal pulse therapy for onychomycosis: a narrative review European Journal of Clinical Pharmacology, 2026
- 縦走性混濁を有する爪甲真菌症に対する10%エフィナコナゾール溶液の臨床的有効性(Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes) The Journal of Dermatology, 2021
- Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised Trials Mycoses, 2025
- Sporotrichosis: An Update on Epidemiology and In Vitro Antifungal Susceptibilities of Sporothrix schenckii Isolated From Humans and Cats in Klang Valley, Malaysia Malaysian Journal of Medicine and Health Sciences, 2024
- Risk factors for the development of tinea pedis and onychomycosis: Real‐world evidence from a single‐podiatry center, large‐scale database in Japan The Journal of Dermatology, 2023
- Biofilm and Dermatophytoma Medical Mycology Journal, 2026
- Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma PLoS neglected tropical diseases, 2022
- A case of a gibberellin-regulated protein-positive patient allergic to various fruits European Journal of Dermatology, 2021
- Onychomycosis: New Developments in Diagnosis, Treatment, and Antifungal Medication Safety Cutis, 2021
- New and Investigational Treatment Options for Dermatomycosis in the Era of Antifungal Resistance Journal of Fungi, 2026
- A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis Medical Mycology Case Reports, 2022
- Exploring the Analgesic Potential of L-Lysine: Molecular Mechanisms, Preclinical Evidence, and Implications for Pharmaceutical Pain Therapy Pharmaceutics, 2025
- Retrospective Study of the Efficacy and Safety of Fosravuconazole Switching Therapy in Patients with Onychomycosis Resistant to Topical Antifungal Treatment 日本臨床皮膚科医会雑誌, 2023
- Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single‐centre retrospective study Journal of the European Academy of Dermatology and Venereology, 2023
- A multicenter retrospective study on the efficacy and safety of fosravuconazole in patients with onychomycosis 日本臨床皮膚科医会雑誌, 2022
- Kerion Celsi due to Microsporum canis in an Adult Woman, Treated Successfully with Fosravuconazole Medical Mycology Journal, 2023
- Efficacy and safety of fosravuconazole in patients with onychomycosis in our clinic 日本臨床皮膚科医会雑誌, 2021
- Tinea Capitis Caused by Trichophyton tonsurans That Responded to Fosravuconazole: The First Detailed Report Medical Mycology Journal, 2025
- Changes in renal function during oral administration of fosravuconazole L-lysine ethanolate (NAILIN® Capsules) in 30 sample sets from 30 patients 日本臨床皮膚科医会雑誌, 2024
- A Randomized, Double Blind Phase II Proof-of-Concept Superiority Trial of Fosravuconazole 200 mg or 300 mg Weekly Dose Versus Itraconazole 400 mg Daily, All Three Arms in Combination With Surgery, in Patients With Eumycetoma in Sudan ClinicalTrials.gov · COMPLETED, 2022
- Treating hard‐to‐heal skin and nail onychomycosis of diabetic foot with plasma therapy Dermatologic Therapy, 2021
- Epitope spreading possibly from BP230 to the NC16A domain of BP180 preceding disease progression in bullous pemphigoid Journal of dermatology (Print), 2020
- A study of 25 cases tested with the dermatophyte test strip after oral foslavuconazole treatment for tinea unguium Journal of dermatology (Print), 2024
- Clinical effectiveness and safety of fosravuconazole L-lysine ethanolate （F-RVCZ） for onychomycosis in elderly patients 日本臨床皮膚科医会雑誌, 2020
- Erythro-papular type drug eruption caused by fosravuconazole L-lysine ethanolate EJD. European journal of dermatology, 2021
- Tinea barbae due to Trichophyton rubrum successfully treated using oral fosravuconazole l ‐lysine ethanolate Journal of dermatology (Print), 2020
- Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies RSC medicinal chemistry, 2021
- Updated Perspectives on the Diagnosis and Management of Onychomycosis Clinical, cosmetic and investigational dermatology, 2022
- Halofantrine Hydrochloride Acts as an Antioxidant Ability Inhibitor That Enhances Oxidative Stress Damage to Candida albicans Antioxidants (Basel, Switzerland), 2024
- A Bibliometric Analysis of the Top 100 Highly Cited Onychomycosis Publications Using SCOPUS Database (1972-2022) Skin appendage disorders, 2023
- Recent advances in therapies for onychomycosis and its management F1000Research, 2019
- PhotoChem Reference Chemical Database for the Development of New Alternative Photosafety Test Methods Toxics, 2025
- An update on the development of novel antifungal agents for eumycetoma Frontiers in pharmacology, 2023
- Genotyping and drug susceptibility profiling of Prototheca sp. strains isolated from cases of protothecosis in dogs Journal of veterinary internal medicine, 2025
- Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris Journal of fungi (Basel, Switzerland), 2024
- The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration Parasites & vectors, 2023
- Dermatophytomas: Clinical Overview and Treatment Journal of fungi (Basel, Switzerland), 2022
- Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics The Journal of clinical and aesthetic dermatology, 2024
- The Significance of Mono- and Dual-Effective Agents in the Development of New Antifungal Strategies Chemical biology & drug design, 2025
- Onychomycosis: Old and New Journal of fungi (Basel, Switzerland), 2023
- Resistance and Recalcitrance in Dermatophytosis: Mechanistic and Clinical Considerations for Keratinized Tissues Antibiotics (Basel, Switzerland), 2026
- Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes Infection and drug resistance, 2024
- Treatment Outcome With Fosravuconazole L-lysine Ethanolate (F-RVCZ) for Onychomycosis 2021
- A Case of Kerion Celsi due to Trichophyton rubrum Successfully Treated with Fosravuconazole Medical mycology journal, 2026
- Development of E1224 by leveraging a strategic partnership for the medicines creation against neglected tropical diseases Parasitology international, 2021
- A Case of Tinea Faciei, Tinea Corporis, and Tinea Unguium with Dermatophytoma Successfully Treated with Oral Fosravuconazole L-lysine Ethanolate Medical mycology journal, 2021
- Effects of additional oral fosravuconazole l-lysine ethanolate therapy following inadequate response to initial treatment for onychomycosis: A multicenter, randomized controlled trial The Journal of dermatology, 2024
- Drug properties of fosravuconazole L-lysine ethanolate (NAILIN® Capsules 100 mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2019
- Kidney injury associated with fosravuconazole L-lysine ethanolate Clinical and experimental nephrology, 2025
- New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial The Lancet. Infectious diseases, 2021
- 爪真菌症の治療における新規経口トリアゾール系抗真菌薬であるfosravuconazole L-lysine ethanolate付加物の有効性と安全性 多施設共同二重盲検無作為化第III相試験(Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study) The Journal of dermatology, 2018
- Treatment Outcome with Fosravuconazole for Onychomycosis Mycopathologia, 2021
- Outcome of fosravuconazole treatment for onychomycosis refractory to topical antifungal agents The Journal of dermatology, 2023
- Diagnosis of Onychomycosis and Real-World Data of Oral Fosravconazole in Japan Medical mycology journal, 2025
- Actualización en el tratamiento de Helicobacter pylori: revisión del LATAMGCHMSG Revista de Gastroenterología del Perú, 2024
- Gastrin and cholecystokinin 2 receptor, and gastrin-releasing peptide receptor in cancer: From pathogenesis to precision medicine Biomedicine & Pharmacotherapy, 2026
- Amprenavir Mitigates Pepsin-Induced Transcriptomic Changes in Normal and Precancerous Esophageal Cells International Journal of Molecular Sciences, 2025
- Comprehensive review of diabetes mellitus: Pathophysiology, current management, and emerging therapeutic approaches International Journal of Pharmacy and Pharmaceutical Science, 2025
- 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) European Journal of Clinical Pharmacology, 2022
- Gut microbiota in dysmenorrhea: causal evidence from Mendelian randomization and microbial-targeted intervention validation Frontiers in Microbiology, 2026
- Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans Pharmaceutics, 2023
- Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions EBioMedicine, 2023
- Interactions between reproductive biology and microbiomes in wild animal species Animal Microbiome, 2021
- Analysis of clinical characteristics and risk factors for digestive system manifestations in rheumatic diseases Srpski arhiv za celokupno lekarstvo, 2026
- Comparing vonoprazan to high-dose proton pump inhibitors for refractory gastroesophageal reflux disease Insights-Journal of Health and Rehabilitation, 2026
- Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Medicine, 2023
- Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy Diagnostics, 2023
- Psychological stress and gut microbiota regulation of osteoarthritis progression: mechanisms and therapeutic strategies Frontiers in microbiology, 2026
- Dislocation of the fibular head in an unusual sports injury: a case report Journal of Medical Case Reports, 2008
- Metallic Air Pollutants and Breast Cancer Risk in a Nationwide Cohort Study Epidemiology, 2019
- Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): A Multi-center Prospective Cohort Study Stroke, 2019
- Sex and survival in non-small cell lung cancer: A nationwide cohort study PLoS ONE, 2019
- Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: A cohort study and systematic review Journal of Neurological Sciences, 2019
- Dissecting the genetic basis of focal cortical dysplasia: a large cohort study Acta Neuropathologica, 2019
- Ultra-Processed Food Consumption Is Associated with Abdominal Obesity: A Prospective Cohort Study in Older Adults Nutrients, 2020
- Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study The Lancet, 2019
- Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study BMC Pulmonary Medicine, 2020
- Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study British medical journal, 2019
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study British medical journal, 2018
- Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers BMC Cancer, 2020
- Oral Anticoagulant and Reduced Risk of Dementia in Patients with Atrial Fibrillation: A Population-Based Cohort Study Heart Rhythm, 2020
- Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study JAMA Oncology, 2019
- Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study Annals of Intensive Care, 2020
- Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study Clinical Infectious Diseases, 2020
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study Lancet Neurology, 2020
- Ultra-processed food consumption and type 2 diabetes incidence: A prospective cohort study Clinical Nutrition, 2020
- Molecular and Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae in the United States: a Prospective Cohort Study Lancet. Infectious Diseases (Print), 2020
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank BMC Medicine, 2020
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study Lancet Neurology, 2013
- Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study Proceedings of the National Academy of Sciences of the United States of America, 2021
